Gas Arabian Services Company (TADAWUL:9528)

Verve Therapeutics Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,815	2,722	1,169	931	-	-
Market Cap Growth	132.83%	132.83%	25.61%	-	-	-
Enterprise Value	2,647	2,663	1,141	916	-	-
Last Close Price	17.83	16.99	6.99	5.36	-	-
PE Ratio	24.72	23.88	14.35	13.81	-	-
PS Ratio	2.58	2.49	1.62	1.88	-	-
PB Ratio	6.96	6.73	3.24	2.93	-	-
P/TBV Ratio	6.96	6.73	3.24	2.94	-	-
P/FCF Ratio	21.36	20.66	44.90	14.70	-	-
P/OCF Ratio	14.57	14.09	19.54	14.16	-	-
EV/Sales Ratio	2.42	2.44	1.58	1.85	-	-
EV/EBITDA Ratio	21.36	28.22	22.56	19.68	-	-
EV/EBIT Ratio	23.90	32.14	25.28	21.49	-	-
EV/FCF Ratio	20.09	20.20	43.81	14.46	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.04	0.12
Debt / EBITDA Ratio	0.05	0.05	0.07	0.02	0.26	0.41
Debt / FCF Ratio	0.04	0.04	0.14	0.02	-	-
Asset Turnover	1.53	1.53	1.33	1.04	0.90	0.78
Inventory Turnover	17.36	17.36	13.52	15.15	13.80	14.54
Quick Ratio	1.26	1.26	1.65	1.88	1.90	1.84
Current Ratio	1.52	1.52	2.13	2.38	2.20	2.03
Return on Equity (ROE)	29.79%	29.79%	24.04%	22.64%	23.17%	31.87%
Return on Assets (ROA)	7.27%	7.27%	5.19%	5.58%	5.43%	10.07%
Return on Capital (ROIC)	13.38%	13.38%	8.26%	8.78%	8.37%	15.82%
Return on Capital Employed (ROCE)	18.30%	18.30%	11.20%	12.10%	12.00%	24.60%
Earnings Yield	4.05%	4.19%	6.97%	7.24%	-	-
FCF Yield	4.68%	4.84%	2.23%	6.80%	-	-
Dividend Yield	2.58%	2.24%	-	4.20%	-	-
Payout Ratio	62.23%	62.23%	43.64%	46.89%	49.95%	73.66%
Buyback Yield / Dilution	0.12%	0.12%	0.14%	-2.05%	-3.21%	-
Total Shareholder Return	2.70%	2.35%	0.14%	2.14%	-3.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.